You are here
Creating Cures Through Facility Investments
Pfizer continues to invest in the groundbreaking science and technology needed to discover tomorrow’s life-saving treatments for patients who need them the most. Our research, development, and manufacturing facilities across the country are fostering next-generation healthcare innovation while creating 30,000 U.S.-based jobs.
Columns:
Body:
Title:
Our Latest Developments
Body:
In 2019, we invested nearly $1 billion in new and existing facilities to fulfill our commitment to deliver breakthroughs that change patients' lives. Our latest investments include:
- An expansion of our manufacturing facility in Sanford, North Carolina, including a new facility for producing and supplying critical, potentially life-changing gene therapies to patients living with rare diseases around the world.
- A new, state-of-the-art research and development facility in Chesterfield, Missouri, dedicated to discovering new biologic therapies and vaccines.
- A new manufacturing facility at our Andover, Massachussetts, campus that produces advanced clinical supplies and accelerates the development of important treatments for patients.
Body:
We are committed to investing in first-in-class science that brings thousands of jobs to the American economy and deliver breakthroughs that change patients' lives.
Learn more about some of our other research and development facilities below.
Body:
